MODULATORS OF THE TRANSMEMBRANE BEHAVIOR REGULATOR OF CYSTIC FIBROSIS
DOP2026000095AUndetermined Publication Date: 2026-06-15VERTEX PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- DO2026000095
- Authority / Receiving Office
- DO · DO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-03
- Filing Date
- 2026-04-01
- Publication Date
- 2026-06-15
Abstract
This description provides modulators of the cystic fibrosis transmembrane conductance regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treating CFTR-mediated diseases, including cystic fibrosis, by using such modulators and pharmaceutical compositions, combination pharmaceutical compositions and combination therapies employing such modulators, and processes and intermediate products for manufacturing such modulators.
Need to check novelty before this filing date? Find Prior Art